FOLR1 and breast carcinoma: Independent validation of these studies with larger clinical populations and by additional technical means of measuring FOLR1 expression will provide useful information into understanding the extent of FOLR1 overexpression in breast cancer subtypes and its association with clinicopathological parameters.